- Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report
Fabiana Pani et al, 2017, Oncology Letters CrossRef - TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma
Gustavo C. Penna et al, 2018, Endocrine CrossRef - Thyroglobulin in differentiated thyroid cancer
Carol Evans et al, 2015, Clinica Chimica Acta CrossRef - Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
Fabiana Pani et al, 2015, Thyroid CrossRef - Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link?
Fabiana Pani et al, 2017, European Journal of Endocrinology CrossRef - Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin
Min Liu et al, 2018, Scientific Reports CrossRef - Evaluation of Clinical Outcomes of Antiangiogenic-Targeted Therapy in Patients with Pulmonary Metastatic Renal Cell Carcinoma Using Non–Contrast-Enhanced Computed Tomography
Guang-yu Wu et al, 2014, Academic Radiology CrossRef - Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?
Fabián Pitoia, 2014, Endocrine-Related Cancer CrossRef - Management of Distant Metastasis in Differentiated Thyroid Cancer
David A. Pattison et al, 2018, Evidence-Based Endocrine Surgery CrossRef - Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review
Jung Han Kim, 2016, Oncotarget CrossRef - Investigating the impact of target lesion selection on drug effect evaluation and tumour growth rate determination using tumour growth inhibition models: Example of malignant pleural mesothelioma patients treated with cisplatin alone or in combination with pemetrexed
Aurélie Lombard et al, 2021, European Journal of Pharmaceutical Sciences CrossRef